Knocking down MIG7 impaired the proliferation, invasiveness and VEGFA expression of SKOV3 cells, and retarded tumor growth, reduced the formation of tumor-associated blood vessels in vivo and improved host survival after these cells were grafted. The gene discussed is BCAR3; the disease is neoplasm.